Globally, liver disease accounts for around two million deaths per year, with around one million of those due to cirrhosis and one million due to viral hepatitis and hepatocellular carcinoma.1 For decades, liver biopsy has been the conventional method for disease assessment, and more recently MR Proton Density Fat Fraction (MR-PDFF) has been added to measure liver fat. Today, ultrasound provides a noninvasive, accessible alternative to these methods.
Demonstrated results in liver ultrasound
200%
improved spatial resolution
200%
improved spatial resolution
Super Resolution MVI offers an improvement of more than 200% in spatial resolution for EPIQ Contrast-enhanced Ultrasound.2
55%
decrease in button pushes
55%
decrease in button pushes
Quick Launch Preset offers 55% decrease in button pushes during an abdominal exam.6
85%
more efficient crystals
85%
more efficient crystals
The uniform crystals of PureWave are 85% more efficient than traditional piezoelectric (PZT) material in converting electrical input into acoustic output.4
A comprehensive solution
Philips offers a comprehensive ultrasound solution to support the assessment, treatment and monitoring of liver disease. Four of our key innovations – PureWave, ElastQ and LFQ, Fusion and Navigation and Contrast-Enhanced Ultrasound (CEUS) – combine for the ultimate liver ultrasound solution.
Image quality, advanced insights, workflow and support
Image quality: Improve penetration while maintaining excellent detail resolution, Doppler sensitivity and CEUS performance.
Advanced insights: Assess tissue stiffness in real time, quantitatively assess steatosis, study liver lesion enhancement patterns in real time and effectively plan interventions.
Workflow: Streamline workflow with fewer button pushes and an ergonomic and intuitive design.
A trusted partner: Experience a partner who offers support that is tailored to your needs and teams.
Supporting liver ultrasound imaging capabilities
Auto ElastQ is designed to improve the quality and consistency of liver elastography by providing assistance with the best frame selection and ROI location.
The C5-1 PureWave transducer features pure, uniform crystals that are 85% more efficient than conventional piezoelectric material1 and an ergonomic design for a reduction in pain and fatigue.2
Liver Fat Quantification (LFQ) tools enable clinicians to measure fatty liver infiltration during a standard liver ultrasound exam.
Philips Fusion and Navigation co-registers CT, MR, or PET images with live ultrasound in under one minute.3
Liver Fat Quantification-CEUS Time of Arrival map of a hemangioma
Liver cyst 3D invert ultrasound
Now that there is a quantitative way of measuring liver fat, it will make it a lot easier for us to let the referring physician determine where the patient is quantitatively on the NAFLD spectrum.
Asrani et al, Burden of liver disease in the world. Journal of hepatology, Vol 70, Issue 1, 2019.
When compared to previous Philips MVI capability.
Clinical effectiveness of PureWave technology in imaging obese patients, Oct 2012.
A comprehensive solution using the Philips eL18-4 PureWave linear transducer, 2018.
When comparing release 10 performance to release 7 performance
Marketing claim evidence for VM12.0 workflow efficiency Quick Launch Preset.
Disclaimer
Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. Results in other cases may vary.